ClinicalTrials.Veeva

Menu

Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

C

Caen University Hospital

Status

Active, not recruiting

Conditions

Thromboembolism
Atrial Fibrillation
Cancer
Bleeding

Treatments

Other: event occurence

Study type

Observational

Funder types

Other

Identifiers

NCT05563883
PMSI_092022

Details and patient eligibility

About

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known.

The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

Enrollment

5,000,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult hospitalized patients
  • with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information)

Exclusion criteria

  • children

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems